Is the Physiological Composition of the Vaginal Microbiome Altered in High-Risk HPV Infection of the Uterine Cervix?


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
27 09 2022
Historique:
received: 29 07 2022
revised: 20 09 2022
accepted: 23 09 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 29 10 2022
Statut: epublish

Résumé

Cervical cancer is the fourth most common malignancy and fourth leading cause of cancer death in women worldwide. More than 99.7% of cases are caused by human papillomavirus (HPV), while HPV types 16 and 18 cause over 70% of all cervical cancer cases. In this preliminary study, we aimed to investigate the presence of HPV infection and diversity of bacteria associated with bacterial vaginosis. Cervical swabs ( HPV16 was the dominant genotype in 53% (9/17) of patients with confirmed precancerous lesions (ASCUS, LSIL, and HSIL). In specimens with confirmed cytological abnormalities and hrHPV infection, we detected a wide diversity of microbes, while the most common species were In our work, HPV16 dominated in patients with cervical precancerous lesions. We also suggest an increased bacterial diversity of the vaginal microbiome in patients with cervical lesions, for which the HPV virus is largely responsible.

Sections du résumé

BACKGROUND
Cervical cancer is the fourth most common malignancy and fourth leading cause of cancer death in women worldwide. More than 99.7% of cases are caused by human papillomavirus (HPV), while HPV types 16 and 18 cause over 70% of all cervical cancer cases. In this preliminary study, we aimed to investigate the presence of HPV infection and diversity of bacteria associated with bacterial vaginosis.
METHODS
Cervical swabs (
RESULTS
HPV16 was the dominant genotype in 53% (9/17) of patients with confirmed precancerous lesions (ASCUS, LSIL, and HSIL). In specimens with confirmed cytological abnormalities and hrHPV infection, we detected a wide diversity of microbes, while the most common species were
CONCLUSION
In our work, HPV16 dominated in patients with cervical precancerous lesions. We also suggest an increased bacterial diversity of the vaginal microbiome in patients with cervical lesions, for which the HPV virus is largely responsible.

Identifiants

pubmed: 36298685
pii: v14102130
doi: 10.3390/v14102130
pmc: PMC9607109
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636
pubmed: 18354839
J Mol Diagn. 2006 Feb;8(1):113-8
pubmed: 16436642
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Virology. 2004 Jun 20;324(1):17-27
pubmed: 15183049
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7
pubmed: 20534435
Virology. 2013 Oct;445(1-2):169-74
pubmed: 23800545
J Cell Physiol. 2015 Apr;230(4):806-12
pubmed: 25205602
Cancer Immunol Immunother. 2010 Nov;59(11):1727-37
pubmed: 20706715
J Infect Dis. 2010 Dec 15;202(12):1789-99
pubmed: 21067372
Sex Transm Infect. 2016 Sep;92(6):441-6
pubmed: 26825087
J Infect Dis. 2014 Dec 1;210(11):1723-33
pubmed: 24943724
Probiotics Antimicrob Proteins. 2018 Jun;10(2):236-242
pubmed: 29071554
J Infect Dis. 2010 Dec 15;202(12):1907-15
pubmed: 21067371
Trends Microbiol. 2017 Mar;25(3):182-191
pubmed: 27914761
Int J Cancer. 2015 Jun 15;136(12):2752-60
pubmed: 25043222
Microbiol Spectr. 2016 Dec;4(6):
pubmed: 28087949
Front Public Health. 2021 Jan 08;8:587298
pubmed: 33490017
J Low Genit Tract Dis. 2014 Jul;18(3):273-80
pubmed: 24477172
Microbiologyopen. 2020 Mar;9(3):e977
pubmed: 31927795
BMC Med. 2012 Jul 12;10:72
pubmed: 22788922
J Immunol. 2014 Sep 1;193(5):2248-57
pubmed: 25063870
Clin Infect Dis. 2003 Aug 1;37(3):319-25
pubmed: 12884154
Ann Ig. 2013 Sep-Oct;25(5):443-56
pubmed: 24048183
J Obstet Gynaecol. 2020 Jul;40(5):602-608
pubmed: 31500479
Int J Mol Sci. 2021 Jun 17;22(12):
pubmed: 34204294
Clin Microbiol Infect. 2015 Jul;21(7):674.e1-9
pubmed: 25752224
Ann Transl Med. 2020 Feb;8(4):100
pubmed: 32175393
J Infect Dis. 1999 Dec;180(6):1863-8
pubmed: 10558942
Anal Biochem. 2010 Oct 15;405(2):224-9
pubmed: 20599650
J Clin Microbiol. 2000 Jan;38(1):357-61
pubmed: 10618116
Sex Transm Dis. 2014 Nov;41(11):660-4
pubmed: 25299412
Jundishapur J Microbiol. 2015 Oct 17;8(10):e22913
pubmed: 26587206
Microb Pathog. 2021 Mar;152:104617
pubmed: 33207260
PLoS Pathog. 2020 Mar 26;16(3):e1008376
pubmed: 32214382
Front Cell Infect Microbiol. 2020 Jun 25;10:307
pubmed: 32670895
Arch Microbiol. 2014 Sep;196(9):645-53
pubmed: 24919535
mBio. 2013 Aug 06;4(4):
pubmed: 23919998

Auteurs

Tomas Rokos (T)

Department of Gynecology and Obstetrics, Jessenius Faculty of Medicine, Comenius University in Bratislava, Kollarova 2, 03601 Martin, Slovakia.

Veronika Holubekova (V)

Department of Molecular Oncology and Diagnostics, Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia.

Zuzana Kolkova (Z)

Department of Molecular Oncology and Diagnostics, Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia.

Andrea Hornakova (A)

Department of Molecular Oncology and Diagnostics, Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, Mala Hora 4C, 03601 Martin, Slovakia.

Terezia Pribulova (T)

Department of Gynecology and Obstetrics, Jessenius Faculty of Medicine, Comenius University in Bratislava, Kollarova 2, 03601 Martin, Slovakia.

Erik Kozubik (E)

Department of Gynecology and Obstetrics, Jessenius Faculty of Medicine, Comenius University in Bratislava, Kollarova 2, 03601 Martin, Slovakia.

Kamil Biringer (K)

Department of Gynecology and Obstetrics, Jessenius Faculty of Medicine, Comenius University in Bratislava, Kollarova 2, 03601 Martin, Slovakia.

Erik Kudela (E)

Department of Gynecology and Obstetrics, Jessenius Faculty of Medicine, Comenius University in Bratislava, Kollarova 2, 03601 Martin, Slovakia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH